lobbying_activities: 3486992

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3486992	06ea6567-0738-42bf-82b3-e31f08e06dee	Q4	ELI LILLY AND COMPANY	13392	ELI LILLY AND COMPANY	2025	fourth_quarter	CSP	Multi-lateral threats to IP and the biopharmaceutical industry; Drug importation; Prescription drug value, access and quality	Commerce, Dept of (DOC),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)		2200000	0	0	2026-01-15T15:29:14-05:00